Navigation Links
Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicine's Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
Date:7/25/2011

hitehead Institute at MIT.

Cornerstone's proprietary Altered Energy Metabolism Directed (AEMD) drug platform disrupts biochemical alterations in the conversion of glucose to energy that occur in many types of cancer cells. These essential "bioenergetic" differences are linked to pathways that control, among other things, cancer cell growth and development, as well as various forms of cell death, including apoptosis and necrosis. The platform is designed to produce drugs, such as the company's lead drug CPI-613, that disrupt energy-production pathways whose organization or regulation are altered specifically in cancer cells. CPI- 613 is currently being evaluated in several ongoing Phase I/II trials.

About Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals, Inc. is a privately held company that is committed to changing the way cancer is treated through the discovery and development of innovative therapies capitalizing on the unique metabolic processes of cancer cells. The company's founding members, management and scientific advisory team include pre-eminent scientists focused on cancer cell metabolism, cancer research and drug development. The company's unique approach to targeting cancer metabolism has led to the discovery of first-in-class drugs with the potential to transform the way cancer is treated.  www.CornerstonePharma.com

This release contains forward-looking statements. These statements relate to future events or each company's future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" or "continue", the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors. Although we believe that the
'/>"/>

SOURCE Cornerstone Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia
2. Cornerstone Pharmaceuticals Announces Positive Results of Emulsiphan Safety Study
3. Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
4. Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
5. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
6. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
7. Cornerstone Therapeutics Announces Collaboration with The Cough Company
8. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
9. Cornerstone Therapeutics Announces Management Change
10. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
11. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Texas , March 30, 2015 ... the My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... you to be prepared to manage your #diabetes before ... Endocrinology (ACE) – the charitable, educational and scientific arm ... has joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... on the momentum of the first quarter of 2015, MedScope ... has announced aggressive plans to expand its Medicaid Home and ... models. The first quarter addition of new contracts ... and Louisiana is a result ... coverage in each state. This brings the total to 12 ...
(Date:3/30/2015)... 2015 A team of Chinese and US ... cell-surface receptor that plays a critical role in thrombosis, ... new structural features, which challenge the conventional concepts of ... a new door for future drug discovery. ... March 30, the researchers at Shanghai Institute of ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6
... Nov. 2, 2010 Anthem Blue Cross and ... of its industry-leading transparency initiative beyond major metro ... Silverton to Sterling and everywhere in between can ... that provides medical cost information for 59 specific ...
... Uroplasty Inc. (Nasdaq: UPI ), ... Services (CMS) has published, in the November, 2010 Federal ... Tibial Nerve Stimulation (PTNS). Uroplasty,s Urgent® PC Neuromodulation System ... 2011, this procedure will now be billed under the ...
Cached Medicine Technology:Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 2Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 3Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement Value for Posterior Tibial Nerve Stimulation 2Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement Value for Posterior Tibial Nerve Stimulation 3
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical education and ... expanding its services into Asia in 2015. Innovaacom’s focus ... comes at a time when Asia’s strengthening economy and ... A rapidly growing aging population and changing socio-economic environment ... in Asia. “We are excited to be a part ...
(Date:3/30/2015)... 30, 2015 According to a recently ... hernia repair market will continue to dominate the European ... primarily due to increasing numbers of ventral hernias, and ... , “The significantly large market share represented by ventral ... ASP. We’re seeing a growing use of expensive biologics,” ...
(Date:3/30/2015)... 30, 2015 Vancouver personal injury lawyer ... majority of cases taken up by the firm are ... the lawyers help protect the interests of their clients ... process. The announcement comes across as an achievement for ... to provide convenience to their client, without compromising their ...
(Date:3/30/2015)... This report studies the global ... 2014 to 2019. , Based on the type ... classified into four major segments, namely radio-frequency, microwave, ... HIFU and laser ablation) segments. Moreover, based on ... is classified into three segments, namely, interventional radiology, ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3
... the International Monetary Fund on Tuesday gave an optimistic ... dark clouds on the horizon// included worries about the ... global avian flu outbreak in humans could cause high ... settlements, trading and communications, the IMF warned in its ...
... has been fined ?100,000 after pleading guilty in the ... a routine operation//. The trust has pleaded guilty for ... ,Sitting at Winchester Crown Court, Mr Justice Cresswell also ... the health and safety prosecution prompted by the death ...
... introduce an incentives scheme to ease the nursing shortage ... to take on certain work done by GPs. ... The government is expanding a program aimed at addressing ... the incentives scheme. ,Federal Health Minister Tony ...
... is launching a cancer-fighting tomato. The supermarket giant has said ... to the tune of almost twice that found in normal ... color to the tomatoes and is rich in anti-oxidants. It ... cancer. A previous study had found that eating 10 servings ...
... Lanka has increased in multifold with people consuming the poisonous seeds ... trivial reasons. ,This is an ornamental plant often used ... trumpet-like flowers and a fruit the size of a conker. Inside ... enough to kill you, the online edition of BBC News reported. ...
... to a study, patients with breast cancer, who are socially ... to die of the disease// than those who are socially ... Kroenke, women diagnosed with breast cancer should know that people ... the disease, reported news portal All Headline News. ...
Cached Medicine News:Health News:IMF considers Bird Flu to be a Dark Cloud 2Health News:Hospital Trust Fined ?100,000 after Patient Deat 2Health News:Nurses To Take On More Work Usually Done By GP’ 2
Anatomical implants for the entire hand, in five sizes...
Nucleus manipulator used during phacoemulsification. Used to break-up the nuclues within the capsular bag during two-handed phaco techniques. Blunt round tip, angled 40 degrees, 6mm from tip. Tip ang...
... original Magstim design the new Magstim 200 ... of knowledge and expertise gathered in both ... an innovative design that will help further ... system of preferred choice. Ergonomic modular ...
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
Medicine Products: